Leif E Sander,Christian Trautwein,Christian Liedtke
Leif E Sander
Hepatocellular carcinoma (HCC), the most common liver cancer, occurs mainly in men. Similar gender disparity is seen in mice given a chemical carcinogen, diethylnitrosamine (DEN). DEN administration caused greater increases in serum interle...
Geotherapeutics of primary biliary cirrhosis: bright and sunny around the Mediterranean but still cloudy and foggy in the United Kingdom [0.03%]
原发性胆汁性肝硬化的地治疗学：地中海地区阳光明媚，但在英国仍多雾不明
Christophe Corpechot,Raoul Poupon
Christophe Corpechot
Impact of weight-based ribavirin with peginterferon alfa-2b in African Americans with hepatitis C virus genotype 1 [0.03%]
基于体重的利巴韦林联合派罗干扰素α-2b治疗基因1型感染的美国黑人患者的疗效分析
Ira M Jacobson,Robert S Brown Jr,Jonathan McCone et al.
Ira M Jacobson et al.
WIN-R (Weight-based dosing of pegINterferon alfa-2b and Ribavirin) was a multicenter, randomized, open-label, investigator-initiated trial involving 236 community and academic sites in the United States, comparing response to pegylated inte...
Randomized Controlled Trial
Hepatology (Baltimore, Md.). 2007 Oct;46(4):982-90. DOI:10.1002/hep.21670 2007
"I'll never touch it again, doctor!"--harmful drinking after liver transplantation [0.03%]
“医生，我再也不喝了吧！”——肝移植术后有害饮酒不容忽视
Paul S Haber,Geoffrey W McCaughan
Paul S Haber
Background: Alcohol relapse can negatively influence the outcome after liver transplantation (LT). The aim of our study was to identify factors that could be associated with the recurrence of harmful alcohol consumption a...
Oyekoya T Ayonrinde,John K Olynyk
Oyekoya T Ayonrinde
Acetaminophen toxicity: changing perceptions on a social/medical issue [0.03%]
acetaminophen中毒：重新审视一个社会和医学问题
William M Lee
William M Lee
Re-evaluating the use of growth factors as adjuvant treatment of chronic hepatitis C [0.03%]
重新评估生长因子作为慢性丙型肝炎辅助治疗的使用效果
Howard J Worman
Howard J Worman
Giovanni B Gaeta,Tommaso Stroffolini,Antonina Smedile et al.
Giovanni B Gaeta et al.
Bioinformatics as tool to identify gene/protein-pathways associated with nonalcoholic fatty liver disease/nonalcoholic steatohepatitis [0.03%]
生物信息学在非酒精性脂肪肝/非酒精性脂肪肝炎相关基因／蛋白通路上的应用研究工具
Anna Alisi,Matilde Marcellini,Valerio Nobili
Anna Alisi
Giovanni Targher
Giovanni Targher